Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
VT-1161
print preview
bookmark
share with colleague
General Information
Company
Viamet Pharmaceuticals Inc.
Description
Small molecule metalloenzyme inhibitor of cytochrome P450 C-14 alpha demethylase (CYP51)
Molecular Target
Cytochrome P450 C-14 alpha demethylase (CYP51)
Mechanism of Action
Latest Stage of Development
Phase I
Indication
Fungal infection
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy